Your browser doesn't support javascript.
Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
Avatef Fazeli, Manouchehr; Rezaei, Leila; Javadirad, Etrat; Iranfar, Khosro; Khosravi, Abbas; Amini Saman, Javad; Poursabbagh, Pardis; Ghadami, Mohammad Rasoul; Parandin, Mohammad Mehdi; Dehghani, Amrollah; Ahmadi Jouybari, Touraj; Mahdavian, Behzad; Eivazi, Nastaran; Rezaei, Sohbat; Rezaei, Alireza; Emami, Bashir; Haqgou, Mohadeseh; Bozorgomid, Arezoo; Sayad, Babak.
  • Avatef Fazeli M; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Rezaei L; Department of Ophthalmology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Javadirad E; Department of Pathology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Iranfar K; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Khosravi A; Department of Ophthalmology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Amini Saman J; Department of Anesthesiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Poursabbagh P; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Ghadami MR; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Parandin MM; Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Dehghani A; Department of Ophthalmology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Ahmadi Jouybari T; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Mahdavian B; Department of Interna, Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Eivazi N; Department of Infectious Disease, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Rezaei S; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Rezaei A; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Emami B; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Haqgou M; Imam Khomeini and Mohamad Kermanshahi Clinical Research Development Unit, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Bozorgomid A; Department of Otorhinolaryngology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Sayad B; Infectious Diseases Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mycoses ; 64(11): 1366-1377, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1305494
ABSTRACT

BACKGROUND:

COVID-19 patients, especially the patients requiring hospitalisation, have a high risk of several complications such as opportunistic bacterial and fungal infections. Mucormycosis is a rare and opportunistic fungal infection that mainly affects diabetic and immunocompromised patients. An increase has been observed in the number of rhino-orbital mucormycosis in patients with COVID-19 admitted to Imam Khomeini Hospital, Kermanshah, Iran, since October 2020. This is a report of the frequency, risk factors, clinical manifestations, treatment and prognosis of COVID-19 associated with mucormycosis infection.

METHODS:

The medical records of COVID-19 patients with rhino-orbital mucormycosis who were diagnosed in an educational therapeutic hospital in Kermanshah, west of Iran were surveyed. Several parameters were analysed including demographic, clinical, therapeutic and laboratory characteristics.

RESULTS:

Twelve patients with COVID-19-associated rhino-orbital mucormycosis were identified from 12 October to 18 November 2020. All cases reported as proven mucormycosis had a history of hospitalisation due to COVID-19. Comorbidities mainly included diabetes mellitus (83.33%) and hypertension (58.33%). Seventy-five per cent of patients received corticosteroids for COVID- 19 treatment. The sites of involvement were rhino-sino-orbital (83%) and rhino-sino (17%). Amphotericin B/liposomal amphotericin B alone or in combination with surgical debridement or orbital exenteration was used as the first-line therapy. The overall mortality rate was 66.7% (8/12).

CONCLUSIONS:

We found a high incidence of mucormycosis among COVID-19 patients. Diabetes mellitus and corticosteroid use were the dominant predisposing factor of mucormycosis. Mucormycosis is a life-threatening and opportunistic infection; therefore, physicians should know the signs and symptoms of the disease so that a timely diagnosis and therapy can be performed.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Orbital Diseases / Rhinitis / COVID-19 / Mucormycosis Type of study: Etiology study / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Mycoses Journal subject: Microbiology Year: 2021 Document Type: Article Affiliation country: Myc.13351

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Orbital Diseases / Rhinitis / COVID-19 / Mucormycosis Type of study: Etiology study / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Mycoses Journal subject: Microbiology Year: 2021 Document Type: Article Affiliation country: Myc.13351